Milestone Pharmaceuticals Inc. - Common Shares — Quarterly Financial Statistics (NASDAQ:MIST) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -13.95 M-12.57 M-9.75 M-12.78 M-16.05 M -51.14 M Cash from investing activities 33.58 M9.94 M-34.98 M2.7 M-80.03 M -102.37 M Cash from financing activities 140 K36 K48.92 M36.43 M94.35 M 179.74 M Free cash flow -13.95 M-12.57 M-9.75 M-12.78 M-16.05 M -51.14 M

News

Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript

Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST)

Milestone Pharmaceuticals: Taking The Long View (NASDAQ:MIST)

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales - Milestone Pharmaceuticals (NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)

Milestone Stock: Downgrading To Sell As CARDAMYST Faces A Tough Reality (NASDAQ:MIST)

Milestone Pharmaceuticals appoints David Sandoval as general counsel

All You Need to Know About Milestone Pharmaceuticals (MIST) Rating Upgrade to Strong Buy

Milestone’s PSVT treatment CARDAMYST now available in US pharmacies